Dynamk Capital

What is Dynamk Capital?

Dynamk Capital is a venture capital firm focused on growth equity investments in life science companies. With a keen emphasis on Life Science Industrials, their investment strategy is about enabling the biopharma continuum through the provision of technologies, tools, and services vital for discovery, development, and manufacturing of therapeutics. Managed by industry experts, Dynamk Capital stands out for their dedication to funding the future of life sciences.

This is evident in their extensive portfolio, showcasing companies that have been selected for their potential to innovate within their respective fields. Dynamk nurtures growth in startups and early-stage companies involved in HealthTech, Medical Devices, Healthcare, and related consumer sectors.

As a seed stage to Series B investor, they are active in empowering businesses that seek to revolutionize industry practices. Their investments range from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot of approximately $1,500,000 for companies that align with their expertise and strategic focus.

The fund prides itself on supporting companies that are building ecosystems and platforms that push the boundaries of the life science industry, aiding in the fight against diseases and improving the quality of health services worldwide. Dynamk Capital's approach is to partner with entrepreneurs who possess the drive and innovation to make a difference, providing not just capital but strategic guidance, access to networks, and industry knowledge.

Based at 30 Wall Street in the heart of New York City, they are strategically positioned to connect with some of the most dynamic entities in the life sciences sector and provide meaningful contributions to their growth and success.

What they say:

We invest in life science industrials - the tools, technologies, and services enabling discovery, development, and manufacturing of the life science industry